Seeking Alpha

Mike Zaman's  Instablog

Mike Zaman
Send Message
  • Evoke Pharma (EVOK) Initiated With A Buy, QIWI Plc (QIWI) Another Strong Quarter 0 comments
    Nov 19, 2013 10:59 PM | about stocks: EVOK, QIWI

    http://static.cdn-seekingalpha.com/uploads/2013/11/19/saupload_evok.jpg Evoke Pharma, Inc. (NASDAQ:EVOK)

    EVOK was initiated with a Buy and price target of $60.00 by brokerage firm Aegis Capital.. Shares of EVOK soared $ 3.59 (or +44.05%) to $11.74 on Tuesday's market activity.

    On September 24, 2013, EVOK priced its initial public offering of 2.1 million shares of common stock at $12.00 per share. On October 3, 2013, the underwriters exercised their over-allotment to purchase an additional 315,000 shares of common stock. The exercise resulted in estimated total net proceeds of $25.1 million, after deducting expenses and underwriting discounts.

    Diabetic gastroparesis is a gastrointestinal disorder afflicting millions of sufferers worldwide, in which the stomach takes too long to empty its contents resulting in serious digestive system symptoms. Metoclopramide is the only product currently approved in the United States to treat gastroparesis, and is currently available only in oral and intravenous forms.

    EVOK is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. By offering a product that can bypass the stomach and directly enter the systemic circulation, EVK-001 potentially allows a more predictable means of delivering the-drug

    http://static.cdn-seekingalpha.com/uploads/2013/11/19/saupload_evok_chart.png

    EVOK is a specialty pharmaceutical company focused primarily on the development of drugs-to treat gastrointestinal disorders and diseases.

    More about Evoke Pharma, Inc. (EVOK) at www.evokepharma.com

    **

    http://static.cdn-seekingalpha.com/uploads/2013/11/19/saupload_qiwi.jpg Qiwi plc (NASDAQ:QIWI)

    The price of QIWI stock surged $2.69 (or +6.40%) to $44.73 per share on Tuesday's trading session, after the company reported another strong quarter on its financial results.

    For the third quarter 2013, QIWI posted adjusted net revenue of RUB 1,622 million ($50.2 million), a 49% increase compared to the same period the prior year, and adjusted net profit of RUB 605 million ($18.7 million), a 56% increase year over year.

    According to its 2013 guidance, QIWI's adjusted net revenue is expected to increase by 42% to 45% over 2012, above the previous guidance of 27% to 30%, while its adjusted net profit is expected to increase by 50% to 55% over 2012, above the previous guidance of 35% to 40%.

    http://static.cdn-seekingalpha.com/uploads/2013/11/19/saupload_qiwi_chart.png

    QIWI is a leading provider of next generation payment services in Russia and the CIS. It has an integrated proprietary network that enables payment services across physical, online and mobile channels.

    More about Qiwi plc (QIWI) at www.qiwi.ru

    **

    Read Full Disclaimer at www.mikezaman.com/disclaimer

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Back To Mike Zaman's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.